How shot is my credibility that you and others take time to read my posts, or to even reply to them en masse? Is it that worth it if I am deemed without credit? If I thought the risk was on my side, I would gladly reveal myself. I am an open book, and I am not perfect, nor are my assumptive/predictive messages, but interestingly, many were dead right. Call it an accident, but I may be batting better than your CEO of the company you hate so, yet frolic amongst the message boards so you can police and inform others of the ill will. I think any smart investor, key word being smart, would know whether or not to waste their time with the company. If you're purely a trader, I get your intentions here, as much as you think you get mine.
If I am wrong, I live another day. If I have anything worth while, I pass it on. If not, I rest well just the same. One shouldn't invest or sell off a MB, so it serves its purpose as informative where and when possible.
Info circling around that a partner may be announced next week. Just a rumor, trading on this is never advised. Been in two meetings this week and it's the only rumblings for what it's worth. I haven't heard from Amarantus in almost a year, not a word and the streets usually aren't silent. We shall see, but seems like someone is hearing something and these are reputable doctors in regeneration.
benfrank: I check in the board every once in a while. I do believe there's a lot of investors in here with honest intent, I also believe there to be a lot of #$%$ just the same anymore. I am very disappointed in many of the choices and direction the company has gone, but let me be clear, it's not all leadership, their misguided promises are the challenge that they will have difficulty breaking through. The science is there, ESS is just a quick plug to stop the bleeding. They will market it and hope it sells quickly and get 50-100m in my opinion after paying everyone off, less the shareholders. I have said numerous times that it will take years for MANF to get traction in the medical community. That is the core in my mind if you're looking at depth and time. Lympro is challenged by one key thing, stubborn behavior. It's speculated that several offers have come in and none were enough.
I think they have something that will change medicine forever. I think they stepped in too deep with intent and didn't formulate a backup plan fast enough. Gerald didn't make promises based on being an idiot with intent, he made them based on assumptive deals, which then makes a good idiot. You hear shareholders scream the most in small companies, thus why the MB is riddled with despair. He let emotion run his business. Do I think this is toxic, no. Most biotechs go through similar patterns and most will accumulate .5 to 1b in debt before their big product(s) take off. Gerald needs to be honest with you all, or he needs to resign.
I don't have enough space on Yahoo to tell you everything I think is wrong, I do think Gerald needs accountability for his emotions and if that doesn't speak to me not being a plant, not sure what does. I still believe in the company, I believe in the pipeline, not a fan of ESS, but get why they did it.
I don't see them going anywhere past Q3 TY without a partner, period. Maybe sad, but true. Best to all